Detalhe da pesquisa
1.
Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial.
Ann Rheum Dis
; 80(3): 339-348, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33168545
2.
Kersten T. Hall, Insulin-the crooked timber: a history from thick brown muck to wall street gold, Oxford: Oxford university press, 2021.
Hist Philos Life Sci
; 45(4): 39, 2023 Oct 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37906414
3.
Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy.
J Infect Dis
; 215(11): 1725-1733, 2017 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28431010
4.
Antiviral Activity, Safety, and Exposure-Response Relationships of GSK3532795, a Second-Generation Human Immunodeficiency Virus Type 1 Maturation Inhibitor, Administered as Monotherapy or in Combination With Atazanavir With or Without Ritonavir in a Phase 2a Randomized, Dose-Ranging, Controlled Trial (AI468002).
Clin Infect Dis
; 65(3): 442-452, 2017 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28369211
5.
Genotypic correlates of susceptibility to HIV-1 attachment inhibitor BMS-626529, the active agent of the prodrug BMS-663068.
J Antimicrob Chemother
; 69(3): 573-81, 2014 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-24128669
6.
Abatacept increases T cell exhaustion in early RA individuals who carry HLA risk alleles.
Front Immunol
; 15: 1383110, 2024.
Artigo
Inglês
| MEDLINE | ID: mdl-38650930
7.
Activity of the HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068, against CD4-independent viruses and HIV-1 envelopes resistant to other entry inhibitors.
Antimicrob Agents Chemother
; 57(9): 4172-80, 2013 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-23774428
8.
Pharmacodynamics, safety, and pharmacokinetics of BMS-663068, an oral HIV-1 attachment inhibitor in HIV-1-infected subjects.
J Infect Dis
; 206(7): 1002-11, 2012 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22896665
9.
Enhanced phosphatase activity attenuates α-synucleinopathy in a mouse model.
J Neurosci
; 31(19): 6963-71, 2011 May 11.
Artigo
Inglês
| MEDLINE | ID: mdl-21562258
10.
In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068.
Antimicrob Agents Chemother
; 56(7): 3498-507, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22547625
11.
Inhibitory effect of selected Indian honey on colon cancer cell growth by inducing apoptosis and targeting the ß-catenin/Wnt pathway.
Food Funct
; 13(15): 8283-8303, 2022 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35834215
12.
HLA-DRB1 risk alleles for RA are associated with differential clinical responsiveness to abatacept and adalimumab: data from a head-to-head, randomized, single-blind study in autoantibody-positive early RA.
Arthritis Res Ther
; 23(1): 245, 2021 09 18.
Artigo
Inglês
| MEDLINE | ID: mdl-34537057
13.
Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measure.
Lancet Rheumatol
; 3(8): e553-e562, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-38287621
14.
HR-2 mutations in human immunodeficiency virus type 1 gp41 restore fusion kinetics delayed by HR-1 mutations that cause clinical resistance to enfuvirtide.
J Virol
; 83(7): 2989-95, 2009 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-19153234
15.
Baseline resistance of primary human immunodeficiency virus type 1 strains to the CXCR4 inhibitor AMD3100.
J Virol
; 82(23): 11695-704, 2008 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-18799588
16.
Resistance profile of the HIV-1 maturation inhibitor GSK3532795 in vitro and in a clinical study.
PLoS One
; 14(10): e0224076, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31622432
17.
Immunohistochemical evaluation of stress-responsive protein sestrin2 and its correlation with p53 mutational status in eyelid sebaceous gland carcinoma.
Br J Ophthalmol
; 102(6): 848-854, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29478030
18.
The Second-Generation Maturation Inhibitor GSK3532795 Maintains Potent Activity Toward HIV Protease Inhibitor-Resistant Clinical Isolates.
J Acquir Immune Defic Syndr
; 75(1): 52-60, 2017 05 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28234686
19.
Efficacy, safety, bone and metabolic effects of HIV nucleoside reverse transcriptase inhibitor BMS-986001 (AI467003): a phase 2b randomised, controlled, partly blinded trial.
Lancet HIV
; 3(1): e13-22, 2016 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-26762988
20.
Changes in biomarkers in HIV-1-infected treatment-naive patients treated with tenofovir DF/emtricitabine plus atazanavir/ritonavir or lopinavir/ritonavir for 96 weeks: the CASTLE biomarker substudy.
Antivir Ther
; 19(7): 693-9, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24739445